Vis enkel innførsel

dc.contributor.authorCarling, Cheryl L Len
dc.contributor.authorKristoffersen, Doris Toveen
dc.contributor.authorFlottorp, Signeen
dc.contributor.authorFretheim, Atleen
dc.contributor.authorOxman, Andrew Daviden
dc.contributor.authorSchünemann, Holger Jen
dc.contributor.authorAkl, Elie Aen
dc.contributor.authorHerrin, Jephen
dc.contributor.authorMacKenzie, Thomas Den
dc.contributor.authorMontori, Victor Men
dc.date.accessioned2009-10-11T19:31:49Znb_NO
dc.date.accessioned2016-02-08T14:19:49Z
dc.date.available2009-10-11T19:31:49Znb_NO
dc.date.available2016-02-08T14:19:49Z
dc.date.issued2009-08-25nb_NO
dc.identifier.citationPLoS medicine 2009, 6 (8):e1000140en
dc.identifier.issn1549-1676nb_NO
dc.identifier.urihttp://hdl.handle.net/11250/2377926
dc.description.abstractBACKGROUND: We conducted an Internet-based randomized trial comparing four graphical displays of the benefits of antibiotics for people with sore throat who must decide whether to go to the doctor to seek treatment. Our objective was to determine which display resulted in choices most consistent with participants' values. METHODS AND FINDINGS: This was the first of a series of televised trials undertaken in cooperation with the Norwegian Broadcasting Company. We recruited adult volunteers in Norway through a nationally televised weekly health program. Participants went to our Web site and rated the relative importance of the consequences of treatment using visual analogue scales (VAS). They viewed the graphical display (or no information) to which they were randomized and were asked to decide whether to go to the doctor for an antibiotic prescription. We compared four presentations: face icons (happy/sad) or a bar graph showing the proportion of people with symptoms on day three with and without treatment, a bar graph of the average duration of symptoms, and a bar graph of proportion with symptoms on both days three and seven. Before completing the study, all participants were shown all the displays and detailed patient information about the treatment of sore throat and were asked to decide again. We calculated a relative importance score (RIS) by subtracting the VAS scores for the undesirable consequences of antibiotics from the VAS score for the benefit of symptom relief. We used logistic regression to determine the association between participants' RIS and their choice. 1,760 participants completed the study. There were statistically significant differences in the likelihood of choosing to go to the doctor in relation to different values (RIS). Of the four presentations, the bar graph of duration of symptoms resulted in decisions that were most consistent with the more fully informed second decision. Most participants also preferred this presentation (38%) and found it easiest to understand (37%). Participants shown the other three presentations were more likely to decide to go to the doctor based on their first decision than everyone based on the second decision. Participants preferred the graph using faces the least (14.4%). CONCLUSIONS: For decisions about going to the doctor to get antibiotics for sore throat, treatment effects presented by a bar graph showing the duration of symptoms helped people make decisions more consistent with their values than treatment effects presented as graphical displays of proportions of people with sore throat following treatment. CLINICAL TRIALS REGISTRATION: ISRCTN58507086.en
dc.language.isoengen
dc.publisherPublic Library of Scienceen
dc.relation.urihttp://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000140en
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Helsetjeneste- og helseadministrasjonsforskning: 806en
dc.subject.meshChoice Behavioren
dc.subject.meshPharyngitisen
dc.subject.meshAnti-Bacterial Agentsen
dc.subject.meshInterneten
dc.subject.meshMethodsen
dc.subject.meshRisk Assessmenten
dc.subject.meshPatient Participationen
dc.titleThe effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to seek treatment: a randomized trial.en
dc.typeJournal articleen
dc.typePeer revieweden
dc.source.journalPLoS medicineen
dc.identifier.doi10.1371/journal.pmed.1000140nb_NO
dc.identifier.pmid19707579nb_NO
dc.contributor.departmentNorwegian Knowledge Centre for the Health Services, Oslo, Norway. cheryl.carling@kunnskapssenteret.noen


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel